Keisuke Miki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keisuke Miki has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
Mari Miki
Department of Internal Medicine, Tokushima Prefecture Naruto Hospital, Naruto, Japan
21 shared publicationsKazuyuki Tsujino
Department of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center , Osaka
18 shared publicationsKenji Yoshimura
Dept of Respiratory Medicine, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan
16 shared publicationsSeigo Kitada
Kitada Resp Clin, 1-57-1 Kyokoji, Yao, Osaka 5810874, Japan
15 shared publicationsRyoji Maekura
Department of Respiratory Medicine, NHO Osaka Toneyama Medical Center, Toyonaka City, Japan
14 shared publicationsHiroyuki Kagawa
Department of Respiratory Medicine, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan
12 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7038
Low Body Mass Index Is Associated with a Long-Term Decline in Accelerometer-Measured Physical Activity in Patients with COPD: An Exploratory Analysis of Participants Co-Enrolled in Two Prospective Cohort Studies
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD), but the factors underlying their long-term change are unclear; we investigated the baseline factors associated with these changes. Methods: Japanese outpatients with stable COPD co-enrolled in the SPACE (baseline) and E-PAC (follow-up) studies were analyzed retrospectively. Twenty-nine baseline clinical variables were assessed. PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annualized percentage changes (per year, relative to baseline) were analyzed by Spearman’s rank correlation and multiple linear regression. Results: Thirty-two participants (all men; median age 71.0 years; median follow-up 5.0 years) were analyzed. Lower baseline body weight, BMI, upper arm circumference, FEV1.0, FEV1.0/FVC, and lowest percutaneous oxygen saturation (SpO2) during the 6 min walk test (6MWT) were correlated with greater annualized declines in PA. For SB, the annualized change was correlated only with the lowest SpO2 during the 6MWT, FEV1.0/FVC, and the hemoglobin concentration. In multivariable models adjusted for FEV1.0 %pred and the lowest SpO2 during the 6MWT, BMI remained associated with the declines in total PA and in the duration at ≥3.0 METs; the models for the step count and SB were not significant. Conclusions: In this exploratory analysis, nutrition-related anthropometric measures, poorer pulmonary function, and exercise-induced desaturation were associated with the long-term decline in PA, and a lower BMI remained associated after adjustment. For the change in SB, associations were found only in unadjusted correlation analysis and were not supported by the multivariable model. These hypothesis-generating findings require confirmation in a larger cohort.
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7038
Open AccessLow Body Mass Index Is Associated with a Long-Term Decline in Accelerometer-Measured Physical Activity in Patients with COPD: An Exploratory Analysis of Participants Co-Enrolled in Two Prospective Cohort Studies
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD), but the factors underlying their long-term change are unclear; we investigated the baseline factors associated with these changes. Methods: Japanese outpatients with stable COPD co-enrolled in the SPACE (baseline) and E-PAC (follow-up) studies were analyzed retrospectively. Twenty-nine baseline clinical variables were assessed. PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annualized percentage changes (per year, relative to baseline) were analyzed by Spearman’s rank correlation and multiple linear regression. Results: Thirty-two participants (all men; median age 71.0 years; median follow-up 5.0 years) were analyzed. Lower baseline body weight, BMI, upper arm circumference, FEV1.0, FEV1.0/FVC, and lowest percutaneous oxygen saturation (SpO2) during the 6 min walk test (6MWT) were correlated with greater annualized declines in PA. For SB, the annualized change was correlated only with the lowest SpO2 during the 6MWT, FEV1.0/FVC, and the hemoglobin concentration. In multivariable models adjusted for FEV1.0 %pred and the lowest SpO2 during the 6MWT, BMI remained associated with the declines in total PA and in the duration at ≥3.0 METs; the models for the step count and SB were not significant. Conclusions: In this exploratory analysis, nutrition-related anthropometric measures, poorer pulmonary function, and exercise-induced desaturation were associated with the long-term decline in PA, and a lower BMI remained associated after adjustment. For the change in SB, associations were found only in unadjusted correlation analysis and were not supported by the multivariable model. These hypothesis-generating findings require confirmation in a larger cohort.
- Open Access
- 19 August 2026
- Published by MDPI AG in Preprints.org
Low Body Mass Index Is Associated with a 5-Year Decline in Accelerometer-Measured Physical Activity in Patients with COPD
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD). However, the factors associated with their long-term change remain unclear. We investigated the baseline factors associated with a longitudinal decline in PA and increase in SB. Methods: Stable outpatients with COPD who participated in both the SPACE (baseline) and E-PAC (follow-up) studies in Japan were analyzed retrospectively. At baseline, 29 clinical variables were assessed, including demographic and anthropometric data, nutritional indices (body mass index [BMI], upper arm circumference), pulmonary function, blood tests, and the lowest percutaneous oxygen saturation (SpO2) during the 6-min walk test (6MWT). PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annual percentage changes were analyzed using Spearman’s rank correlation and multiple linear regression. Analyses were exploratory, with 95% confidence intervals reported. Results: Thirty-two men (median age 71.0 years; median follow-up 5.0 years) were analyzed. Greater annual declines in PA were associated with a poorer baseline nutritional status (lower body weight, BMI, and upper arm circumference), lower pulmonary function, and a lower lowest SpO2 during the 6MWT (i.e., exercise-induced desaturation). A greater annual increase in SB was associated with a lower lowest SpO2 and a higher baseline hemoglobin concentration. In multivariable models, BMI remained independently associated with the declines in total PA and in the duration at ≥3.0 METs. Conclusions: In this exploratory analysis, nutritional status, pulmonary function, and exercise-induced desaturation were associated with long-term behavioral changes in COPD, with BMI showing the most consistent association with the decline in PA. These hypothesis-generating findings require confirmation in a larger cohort.
- 19 August 2026
- Published by MDPI AG in Preprints.org
Open AccessLow Body Mass Index Is Associated with a 5-Year Decline in Accelerometer-Measured Physical Activity in Patients with COPD
Background/Objectives: Reduced physical activity (PA) and increased sedentary behavior (SB) are associated with adverse outcomes in chronic obstructive pulmonary disease (COPD). However, the factors associated with their long-term change remain unclear. We investigated the baseline factors associated with a longitudinal decline in PA and increase in SB. Methods: Stable outpatients with COPD who participated in both the SPACE (baseline) and E-PAC (follow-up) studies in Japan were analyzed retrospectively. At baseline, 29 clinical variables were assessed, including demographic and anthropometric data, nutritional indices (body mass index [BMI], upper arm circumference), pulmonary function, blood tests, and the lowest percutaneous oxygen saturation (SpO2) during the 6-min walk test (6MWT). PA and SB were measured with a waist-worn triaxial accelerometer and expressed in metabolic equivalents (METs). Annual percentage changes were analyzed using Spearman’s rank correlation and multiple linear regression. Analyses were exploratory, with 95% confidence intervals reported. Results: Thirty-two men (median age 71.0 years; median follow-up 5.0 years) were analyzed. Greater annual declines in PA were associated with a poorer baseline nutritional status (lower body weight, BMI, and upper arm circumference), lower pulmonary function, and a lower lowest SpO2 during the 6MWT (i.e., exercise-induced desaturation). A greater annual increase in SB was associated with a lower lowest SpO2 and a higher baseline hemoglobin concentration. In multivariable models, BMI remained independently associated with the declines in total PA and in the duration at ≥3.0 METs. Conclusions: In this exploratory analysis, nutritional status, pulmonary function, and exercise-induced desaturation were associated with long-term behavioral changes in COPD, with BMI showing the most consistent association with the decline in PA. These hypothesis-generating findings require confirmation in a larger cohort.
- 24 April 2026
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (8) , 521-534
Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosis
Pulmonary fibrosis has a poor prognosis due to challenges in early diagnosis and therapeutic intervention. Current treatments remain largely ineffective due to an incomplete understanding of the complex pathology, including the interactions between fibroblasts and profibrotic immune cells within fibrotic lungs. To elucidate the dynamics of fibrosis, we performed single-cell RNA sequencing (scRNA-seq) on bronchoalveolar lavage fluid (BALF) obtained from patients with interstitial lung disease (ILD). We identified the SPP1- and APOE-expressing macrophage population that is commonly present across ILDs. Histological analysis showed that this macrophage population accumulated at the center of fibrotic foci. Furthermore, the ratio of this macrophage population was increased in both progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF). Transcriptomic analysis further divided this macrophage population into two subsets: SLC40A1+ or HAMP+ fibrosis-associated macrophages. We found that the relative balance of IL-10 and IL-8 regulated SLC40A1 and HAMP expression within fibrosis-associated macrophages. Additionally, histological analysis revealed that bronchial epithelium expressed IL-8, while type II alveolar epithelial cells expressed IL-10 in the fibrotic lung. SLC40A1+ fibrosis-associated macrophages localized to CD31+ perivascular regions and mediated the uptake and degradation of the hemoglobin–haptoglobin complex. This dual pathway—providing iron via SLC40A1 and intracellular iron accumulation via HAMP—facilitated the transition of fibroblasts into SPP1+ myofibroblasts. Moreover, ferroptotic fibroblasts secreted TGF-β1, which further contributes to fibrotic progression. In conclusion, aberrant iron metabolism orchestrated by fibrosis-associated macrophages may contribute to fibrosis by facilitating the transition of myofibroblasts. These findings provide mechanistic insight into the progression of autonomous pulmonary fibrosis.
- 24 April 2026
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (8) , 521-534
Distinct fibrosis-associated macrophage subsets coordinate iron metabolism in pulmonary fibrosis
Pulmonary fibrosis has a poor prognosis due to challenges in early diagnosis and therapeutic intervention. Current treatments remain largely ineffective due to an incomplete understanding of the complex pathology, including the interactions between fibroblasts and profibrotic immune cells within fibrotic lungs. To elucidate the dynamics of fibrosis, we performed single-cell RNA sequencing (scRNA-seq) on bronchoalveolar lavage fluid (BALF) obtained from patients with interstitial lung disease (ILD). We identified the SPP1- and APOE-expressing macrophage population that is commonly present across ILDs. Histological analysis showed that this macrophage population accumulated at the center of fibrotic foci. Furthermore, the ratio of this macrophage population was increased in both progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF). Transcriptomic analysis further divided this macrophage population into two subsets: SLC40A1+ or HAMP+ fibrosis-associated macrophages. We found that the relative balance of IL-10 and IL-8 regulated SLC40A1 and HAMP expression within fibrosis-associated macrophages. Additionally, histological analysis revealed that bronchial epithelium expressed IL-8, while type II alveolar epithelial cells expressed IL-10 in the fibrotic lung. SLC40A1+ fibrosis-associated macrophages localized to CD31+ perivascular regions and mediated the uptake and degradation of the hemoglobin–haptoglobin complex. This dual pathway—providing iron via SLC40A1 and intracellular iron accumulation via HAMP—facilitated the transition of fibroblasts into SPP1+ myofibroblasts. Moreover, ferroptotic fibroblasts secreted TGF-β1, which further contributes to fibrotic progression. In conclusion, aberrant iron metabolism orchestrated by fibrosis-associated macrophages may contribute to fibrosis by facilitating the transition of myofibroblasts. These findings provide mechanistic insight into the progression of autonomous pulmonary fibrosis.
- Open Access
- 27 March 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (4)
Gastric Aspirate Isolate Demonstrates Strain-Level Concordance With Sputum Isolate in Nontuberculous Mycobacterial Pulmonary Disease
The nontuberculous mycobacteria (NTM) isolated from gastric aspirate have demonstrated >85% strain concordance with those from the sputum, suggesting that they originate from the lungs rather than the environment. Gastric aspirate, although not yet internationally recognized, may be a useful supplementary specimen for diagnosing NTM pulmonary disease.
- 27 March 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (4)
Open AccessGastric Aspirate Isolate Demonstrates Strain-Level Concordance With Sputum Isolate in Nontuberculous Mycobacterial Pulmonary Disease
The nontuberculous mycobacteria (NTM) isolated from gastric aspirate have demonstrated >85% strain concordance with those from the sputum, suggesting that they originate from the lungs rather than the environment. Gastric aspirate, although not yet internationally recognized, may be a useful supplementary specimen for diagnosing NTM pulmonary disease.
- Open Access
- 18 December 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Exercise alveolar oxygen extraction rate reflects ventilatory efficiency and predicts outcomes in idiopathic pulmonary fibrosis
Oxygen uptake (V’O2) obtained from expiratory gas analysis is generally calculated using minute ventilation (V’E) and the inspired‒expire
- 18 December 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessExercise alveolar oxygen extraction rate reflects ventilatory efficiency and predicts outcomes in idiopathic pulmonary fibrosis
Oxygen uptake (V’O2) obtained from expiratory gas analysis is generally calculated using minute ventilation (V’E) and the inspired‒expire
- Open Access
- 1 May 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 1477-1492
Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study
Background: In Western studies, lung microbiome changes are reported in patients with chronic obstructive pulmonary disease (COPD) and are associated with poorer outcomes, but similar studies in Asian patients or those with less severe COPD are limited. Methods: The Acute Exacerbation and Respiratory InfectionS in COPD Japan (AERIS-J; jRCT1080224632/NCT03957577) was a prospective, non-interventional study to evaluate sputum microbiome diversity at baseline and after 12 months (V2; exploratory analysis), in patients aged 40– 80 years with stable COPD (June 2019–June 2022). Baseline sputum potentially pathogenic organisms (PPOs) were identified. Blood cell counts and COPD Assessment Test (CAT) scores were collected at baseline and COPD symptoms measured over 12 months using the Evaluating Respiratory Symptoms in COPD and EXAcerbations of Chronic pulmonary disease Tool, collected by eDiary. Results: Patients (N=63) had a mean age of 72.8 years, and percent predicted post-bronchodilator forced expiratory volume in 1 second was 58.3%; 92% were male. Across 62 baseline sputum samples, microbiome composition was similar between 16S rRNA/metagenomic datasets. Patients graded Global Initiative for Chronic Obstructive Lung Disease (GOLD) III versus GOLD I/II had minimal differences in their microbial taxonomic profile and no differences in microbial diversity (Wilcoxon P=0.71). Alpha diversity (Shannon index) positively correlated with blood basophils (rho=0.41; P=0.0019) and negatively correlated with CAT score (rho=0.36; P=0.0069). Alpha diversity and sputum (rho: − 0.0637; P=0.7836) or blood (rho: 0.1739; P=0.2043) eosinophils were not correlated. No difference in alpha (P=0.5) or beta (P=0.3) diversity or Operational Taxonomic Unit (Anosim R=− 0.024; P=0.892) was observed between PPO-positive or -negative sputum. Conclusion: A less diverse microbiome correlated with poorer health status and lower blood basophils in patients with COPD and moderate airflow limitation. There was no relationship between PPO presence and microbiome diversity. Plain Language Summary: Chronic obstructive pulmonary disease (COPD) is a progressive lung condition resulting in breathing difficulties. Research has shown that patients with COPD experience changes in the diversity of bacteria in their lungs, leading to a worsening of symptoms. The lung microbiome includes different types of bacteria, and is involved in important roles, such as regulating the immune system and protecting the lung from invading pathogens. Many studies on the microbiome have been based in western countries, and there are few studies among Asian patients and populations with moderate COPD. The aim of this year-long study was to assess the diversity of the lung microbiome in Japanese patients with COPD and moderate airflow limitation, and how it affects patients’ immunity and disease severity. Patients’ sputum and blood samples were obtained at the start of the study and the different types of bacteria in the sputum and the number of immune cells in the blood were measured. Patients’ symptoms were also assessed at study start. Results showed that a less diverse lung microbiome was associated with lower levels of blood immune cells and worse COPD symptoms. These results improve our knowledge of the lung microbiome in an Asian population with COPD, providing insights into how lower bacterial diversity may worsen patient immunity and COPD severity.
- 1 May 2025
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 20, 1477-1492
Open AccessSputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study
Background: In Western studies, lung microbiome changes are reported in patients with chronic obstructive pulmonary disease (COPD) and are associated with poorer outcomes, but similar studies in Asian patients or those with less severe COPD are limited. Methods: The Acute Exacerbation and Respiratory InfectionS in COPD Japan (AERIS-J; jRCT1080224632/NCT03957577) was a prospective, non-interventional study to evaluate sputum microbiome diversity at baseline and after 12 months (V2; exploratory analysis), in patients aged 40– 80 years with stable COPD (June 2019–June 2022). Baseline sputum potentially pathogenic organisms (PPOs) were identified. Blood cell counts and COPD Assessment Test (CAT) scores were collected at baseline and COPD symptoms measured over 12 months using the Evaluating Respiratory Symptoms in COPD and EXAcerbations of Chronic pulmonary disease Tool, collected by eDiary. Results: Patients (N=63) had a mean age of 72.8 years, and percent predicted post-bronchodilator forced expiratory volume in 1 second was 58.3%; 92% were male. Across 62 baseline sputum samples, microbiome composition was similar between 16S rRNA/metagenomic datasets. Patients graded Global Initiative for Chronic Obstructive Lung Disease (GOLD) III versus GOLD I/II had minimal differences in their microbial taxonomic profile and no differences in microbial diversity (Wilcoxon P=0.71). Alpha diversity (Shannon index) positively correlated with blood basophils (rho=0.41; P=0.0019) and negatively correlated with CAT score (rho=0.36; P=0.0069). Alpha diversity and sputum (rho: − 0.0637; P=0.7836) or blood (rho: 0.1739; P=0.2043) eosinophils were not correlated. No difference in alpha (P=0.5) or beta (P=0.3) diversity or Operational Taxonomic Unit (Anosim R=− 0.024; P=0.892) was observed between PPO-positive or -negative sputum. Conclusion: A less diverse microbiome correlated with poorer health status and lower blood basophils in patients with COPD and moderate airflow limitation. There was no relationship between PPO presence and microbiome diversity. Plain Language Summary: Chronic obstructive pulmonary disease (COPD) is a progressive lung condition resulting in breathing difficulties. Research has shown that patients with COPD experience changes in the diversity of bacteria in their lungs, leading to a worsening of symptoms. The lung microbiome includes different types of bacteria, and is involved in important roles, such as regulating the immune system and protecting the lung from invading pathogens. Many studies on the microbiome have been based in western countries, and there are few studies among Asian patients and populations with moderate COPD. The aim of this year-long study was to assess the diversity of the lung microbiome in Japanese patients with COPD and moderate airflow limitation, and how it affects patients’ immunity and disease severity. Patients’ sputum and blood samples were obtained at the start of the study and the different types of bacteria in the sputum and the number of immune cells in the blood were measured. Patients’ symptoms were also assessed at study start. Results showed that a less diverse lung microbiome was associated with lower levels of blood immune cells and worse COPD symptoms. These results improve our knowledge of the lung microbiome in an Asian population with COPD, providing insights into how lower bacterial diversity may worsen patient immunity and COPD severity.
- Open Access
- 8 January 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (3)
Effectiveness of a long-term acupuncture treatment in patients with chronic obstructive pulmonary disease: a randomised controlled trial
Objective: We conducted a 1-year acupuncture intervention trial for patients with chronic obstructive pulmonary disease (COPD) and evaluated measures of quality of life (QOL).Methods: This 52-week randomised clinical trial was conducted in outpatient settings at two general hospitals and two clinics in Japan from January 2013 to October 2018. Forty-five patients were randomly assigned to the usual care group (UG) or the acupuncture treatment group (AG). Participants were patients with COPD classified as stage II or higher according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification. The UG received usual care in accordance with the guidelines, and the AG received acupuncture treatment once a week for 48 times in addition to usual care. Changes in outcome measures were compared using analysis of covariance, with the total domain score from the St. George's Respiratory Questionnaire (SGRQ) measured at baseline and in week 52 as the primary outcome measure.Result: The 45 participants comprised 21 patients in the UG and 24 patients in the AG. In week 52, SGRQ total domain score was significantly improved in the AG compared with the UG (mean [standard deviation] difference from baseline: −22.8 [19.0] in the AGversus6.8 [13.5] in the UG; regression coefficient between groups: −26.9; 95% confidence interval: −35.8 to −17.9). No severe adverse events were reported.Conclusion: This study clearly suggested the long-term effectiveness of acupuncture. Acupuncture may offer a useful adjunctive therapy to improve QOL in COPD patients.
- 8 January 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (3)
Open AccessEffectiveness of a long-term acupuncture treatment in patients with chronic obstructive pulmonary disease: a randomised controlled trial
Objective: We conducted a 1-year acupuncture intervention trial for patients with chronic obstructive pulmonary disease (COPD) and evaluated measures of quality of life (QOL).Methods: This 52-week randomised clinical trial was conducted in outpatient settings at two general hospitals and two clinics in Japan from January 2013 to October 2018. Forty-five patients were randomly assigned to the usual care group (UG) or the acupuncture treatment group (AG). Participants were patients with COPD classified as stage II or higher according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification. The UG received usual care in accordance with the guidelines, and the AG received acupuncture treatment once a week for 48 times in addition to usual care. Changes in outcome measures were compared using analysis of covariance, with the total domain score from the St. George's Respiratory Questionnaire (SGRQ) measured at baseline and in week 52 as the primary outcome measure.Result: The 45 participants comprised 21 patients in the UG and 24 patients in the AG. In week 52, SGRQ total domain score was significantly improved in the AG compared with the UG (mean [standard deviation] difference from baseline: −22.8 [19.0] in the AGversus6.8 [13.5] in the UG; regression coefficient between groups: −26.9; 95% confidence interval: −35.8 to −17.9). No severe adverse events were reported.Conclusion: This study clearly suggested the long-term effectiveness of acupuncture. Acupuncture may offer a useful adjunctive therapy to improve QOL in COPD patients.
- Open Access
- 31 October 2024
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 24 (1) , 1-11
Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease
In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production ( $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2) slope has been reported as a measure of exercise efficiency, but the oxygen uptake efficiency slope (OUES), i.e., the slope of oxygen uptake ( $$\rm{\dot V}$$ O2) versus the logarithmically transformed $$\rm{\dot V}$$ E, has rarely been reported. We hypothesized that the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope is more useful than OUES in clinical use for the pathophysiological evaluation of COPD. Then, we investigated the cardiopulmonary exercise testing parameters affecting each of these slopes in 122 patients with all Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD grades selected from our database. Compared with the GOLD I-II group (n = 51), peak $$\rm{\dot V}$$ O2 (p < 0.0001), OUES (p = 0.0161), $$\rm{\dot V}$$ E at peak exercise (p < 0.0001), and percutaneous oxygen saturation (SpO2) at peak exercise (p = 0.0004) were significantly lower in the GOLD III-IV group (n = 71). The GOLD III-IV group was divided into two groups by the exertional decrease in SpO2 from rest to peak exercise: 3% or less (the non-desaturation group: n = 23), or greater than 3% (the desaturation group: n = 48). OUES correlated only weakly with peak $$\rm{\dot V}$$ O2, $$\rm{\dot V}$$ E at peak exercise, and the difference between inspired and expired mean O2 concentrations (ΔFO2) at peak exercise, i.e., an indicator of oxygen consumption ability throughout the body, in the GOLD III-IV group with exertional hypoxemia. In contrast, the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope was significantly correlated with ΔFO2 at peak exercise, regardless of the COPD grade and exertional desaturation. Across all COPD stages, there was no correlation between the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope and $$\rm{\dot V}$$ E at peak exercise, and stepwise analysis identified peak $$\rm{\dot V}$$ O2 (p = 0.0345) and ΔFO2 (p < 0.0001) as variables with a greater effect on the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope. The OUES may be less useful in advanced COPD with exertional hypoxemia. The $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope, which is independent of $$\rm{\dot V}$$ E, focuses on oxygen consumption ability and exercise tolerance in COPD, regardless of the exertional hypoxemia level and COPD grade. Therefore, the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope might be useful in establishing or evaluating tailor-made therapies for individual patient’s pathologies in COPD as an indicator focusing on oxygen consumption ability.- 31 October 2024
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 24 (1) , 1-11
Open AccessGas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease
In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production ( $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2) slope has been reported as a measure of exercise efficiency, but the oxygen uptake efficiency slope (OUES), i.e., the slope of oxygen uptake ( $$\rm{\dot V}$$ O2) versus the logarithmically transformed $$\rm{\dot V}$$ E, has rarely been reported. We hypothesized that the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope is more useful than OUES in clinical use for the pathophysiological evaluation of COPD. Then, we investigated the cardiopulmonary exercise testing parameters affecting each of these slopes in 122 patients with all Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD grades selected from our database. Compared with the GOLD I-II group (n = 51), peak $$\rm{\dot V}$$ O2 (p < 0.0001), OUES (p = 0.0161), $$\rm{\dot V}$$ E at peak exercise (p < 0.0001), and percutaneous oxygen saturation (SpO2) at peak exercise (p = 0.0004) were significantly lower in the GOLD III-IV group (n = 71). The GOLD III-IV group was divided into two groups by the exertional decrease in SpO2 from rest to peak exercise: 3% or less (the non-desaturation group: n = 23), or greater than 3% (the desaturation group: n = 48). OUES correlated only weakly with peak $$\rm{\dot V}$$ O2, $$\rm{\dot V}$$ E at peak exercise, and the difference between inspired and expired mean O2 concentrations (ΔFO2) at peak exercise, i.e., an indicator of oxygen consumption ability throughout the body, in the GOLD III-IV group with exertional hypoxemia. In contrast, the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope was significantly correlated with ΔFO2 at peak exercise, regardless of the COPD grade and exertional desaturation. Across all COPD stages, there was no correlation between the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope and $$\rm{\dot V}$$ E at peak exercise, and stepwise analysis identified peak $$\rm{\dot V}$$ O2 (p = 0.0345) and ΔFO2 (p < 0.0001) as variables with a greater effect on the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope. The OUES may be less useful in advanced COPD with exertional hypoxemia. The $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope, which is independent of $$\rm{\dot V}$$ E, focuses on oxygen consumption ability and exercise tolerance in COPD, regardless of the exertional hypoxemia level and COPD grade. Therefore, the $$\rm{\dot V}$$ E- $$\rm{\dot V}$$ CO2 slope might be useful in establishing or evaluating tailor-made therapies for individual patient’s pathologies in COPD as an indicator focusing on oxygen consumption ability. - 20 September 2024
- Published by Elsevier in Respiratory Investigation
- Vol. 62 (6) , 1058-1063
Exercise intolerance and oxygen dynamics in nontuberculous mycobacteria with bronchiectasis
- 20 September 2024
- Published by Elsevier in Respiratory Investigation
- Vol. 62 (6) , 1058-1063
Exercise intolerance and oxygen dynamics in nontuberculous mycobacteria with bronchiectasis
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , OA5545
Regulating the larynx by expiratory pressure load training to improve aerobic capacity in advanced COPD: a substudy of the randomised, controlled EPT trial
Rationale: Improvements of exercise tolerance remain inadequate in advanced chronic obstructive pulmonary disease (COPD). The hypothesis that laryngeal narrowing in COPD is a potential treatment target of expiratory pressure load training (EPT) to improve exercise tolerance by obtaining adequate expiration was tested in the EPT study, in which the effect of 3-month EPT was assessed in 47 COPD across all GOLD grades, randomly allocating 1:1 to EPT or control groups. Methods: The aim of this substudy was investigate the effect of EPT with a focus on peak oxygen uptake (V′O2) in GOLD III-IV cases. Results: Compared with controls (n=10), EPT increased (n=10): 1) peak V′O2 with estimated treatment effect (ETE): +2.1 mL×min−1×kg−1, p=0.0004; 2) glottic dilatation ratio (GDR) at maximum collapse on laryngoscopy in the submaximal exercise with ETE: +28%, p=0.0001; and 3) mean expiratory flow (VTex/TE) at peak exercise with ETE: +91 mL× sec−1 p=0.0073, improving the St George’s Respiratory Questionnaire (SGRQ) total with an ETE of -9.7, p=0.0088. Across GOLD III-IV grades, the responses of VTex/TE and GDR at maximum collapse were selected as more influential variables correlating with the improvement in peak V′O2. Conclusion: EPT improved aerobic capacity and health status with higher VTex/TE and larger laryngeal widening in advanced COPD.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , OA5545
Regulating the larynx by expiratory pressure load training to improve aerobic capacity in advanced COPD: a substudy of the randomised, controlled EPT trial
Rationale: Improvements of exercise tolerance remain inadequate in advanced chronic obstructive pulmonary disease (COPD). The hypothesis that laryngeal narrowing in COPD is a potential treatment target of expiratory pressure load training (EPT) to improve exercise tolerance by obtaining adequate expiration was tested in the EPT study, in which the effect of 3-month EPT was assessed in 47 COPD across all GOLD grades, randomly allocating 1:1 to EPT or control groups. Methods: The aim of this substudy was investigate the effect of EPT with a focus on peak oxygen uptake (V′O2) in GOLD III-IV cases. Results: Compared with controls (n=10), EPT increased (n=10): 1) peak V′O2 with estimated treatment effect (ETE): +2.1 mL×min−1×kg−1, p=0.0004; 2) glottic dilatation ratio (GDR) at maximum collapse on laryngoscopy in the submaximal exercise with ETE: +28%, p=0.0001; and 3) mean expiratory flow (VTex/TE) at peak exercise with ETE: +91 mL× sec−1 p=0.0073, improving the St George’s Respiratory Questionnaire (SGRQ) total with an ETE of -9.7, p=0.0088. Across GOLD III-IV grades, the responses of VTex/TE and GDR at maximum collapse were selected as more influential variables correlating with the improvement in peak V′O2. Conclusion: EPT improved aerobic capacity and health status with higher VTex/TE and larger laryngeal widening in advanced COPD.